Naz, LLC v. Philips Healthcare
Filing
220
ORDER AND REASONS: ORDERED that Philips' 139 Motion for Partial Summary Judgment regarding prescription of Plaintiffs' LPLA claim is DENIED. FURTHER ORDERED that Philips' 160 Motion for Partial Summary Judgment regarding prescript ion of Plaintiffs' redhibition claims is DENIED. FURTHER ORDERED that Philips' 163 Motion for Partial Summary Judgment regarding the preclusive effects of the application of the LPLA and Louisiana redhibition law is DENIED. FURTHER ORDER ED that Philips' 141 Motion to Strike Plaintiffs' jury demand is DENIED. FURTHER ORDERED that the Magistrate Judge's 156 Order denying Plaintiffs' Motion for leave to file a second amended complaint is AFFIRMED. Signed by Judge Barry W Ashe on 11/7/2018.(clc)
UNITED STATES DISTRICT COURT
EASTERN DISTRICT OF LOUISIANA
NAZ, LLC
CIVIL ACTION
VERSUS
NO. 17-2882
PHILIPS HEALTHCARE, A DIVISION
OF PHILIPS ELECTRONICS NORTH
AMERICA CORPORATION
SECTION: M (4)
ORDER & REASONS
Before the Court is defendant Philips Healthcare (“Philips”), a Division of Philips
Electronics North America Corporation’s motion for partial summary judgment regarding
prescription of plaintiffs’ Louisiana Products Liability Act (“LPLA”) claim, R. Doc. 139, to
which plaintiffs NAZ, LLC (“NAZ”) and Advanced Neurodiagnostic Center, Inc. (“Ad Neuro”)
(collectively “Plaintiffs”) respond in opposition, R. Doc. 193, and in support of which Philips
replies, R. Doc. 210; Philips’ motion for partial summary judgment regarding prescription of
Plaintiffs’ redhibition claims, R. Doc. 160, to which Plaintiffs respond in opposition, R. Doc.
196, and in support of which Philips replies, R. Doc. 206; Philips’ motion for partial summary
judgment regarding the preclusive effects of the application of the LPLA and Louisiana
redhibition law, R. Doc. 163, to which Plaintiffs respond in opposition, R. Doc. 195, and in
support of which Philips replies, R. Doc. 208; Philips’ motion to strike Plaintiffs’ jury demand,
R. Doc. 141, to which Plaintiffs respond in opposition, R. Doc. 187, and in support of which
Philips replies, R. Doc. 191; and Plaintiffs’ appeal of the Magistrate Judge’s decision denying
their motion for leave to file a second amended complaint, R. Doc. 180, to which Philips
responds in opposition, R. Doc. 199, and in support of which Plaintiffs reply, R. Doc. 213.
Having considered the parties’ memoranda and the applicable law, the Court issues this Order &
Reasons.
I.
BACKGROUND
This litigation arises from a medical facility’s purchase of allegedly faulty MRI
equipment,1 the manufacturer’s allegedly faulty installation and service of the MRI equipment,
as well as its failure to provide the purchaser with the “complete package,” including the
hardware and software components that should have been delivered when the MRI equipment
was installed.
NAZ owns a medical facility at 2909 Kingman Street in Metairie, Louisiana (“medical
facility”).2
Ad Neuro is the operational entity whose employees operate the diagnostic
equipment and service and treat the patients who undergo diagnostic testing.3 The medical
facility was renovated to expand the existing medical center with the addition of a state-of-the-art
neuroscience center and ambulatory surgery center.4 Dr. Morteza Shamsnia, as principal of NAZ
and Ad Neuro, researched MRI equipment for the neuroscience center and eventually chose the
Ingenia 3.0T Omega MRI neurological complete package manufactured and sold by Philips,
which designs, manufactures, tests, markets, sells, installs, and services medical and diagnostic
equipment.5
In December 2011, Dr. Shamsnia, on behalf of NAZ and Ad Neuro, signed a quote
document which set forth the price and components, packages and services Philips promised to
deliver (“Revision 10”).6 Plaintiffs allege that Dr. Shamsnia made a counteroffer to Philips’
quote by adding that the purchase and acceptance of the terms and conditions were contingent
upon Philips’ providing financing for the purchase of the MRI equipment with a 3.9% interest
1
MRI, or magnetic resonance imaging, is non-invasive imaging technology that, using a large magnet and
radio waves, produces three-dimensional detailed anatomical images or organs and structures inside the body.
2
R. Doc. 47 at 1.
3
Id. at 1-2.
4
Id. at 2.
5
Id. at 2 & 11.
6
Id. at 3.
2
rate.7 Philips never signed Revision 10, and Plaintiffs allege that negotiations were ongoing
regarding the terms and conditions of the sale.8
Moreover, Plaintiffs allege that Phillips misrepresented that it had the authority to offer
the financing terms required by Dr. Shamsnia.9 In particular, Plaintiffs allege they learned that
Philips and its alleged financing entity, Philips Medical Capital (“PMC”), were wholly separate
entities, and that PMC had sole control of any financing agreement related to the sale of the MRI
equipment, in August 2016 when PMC placed them in default of their loan.10
In May 2012, Philips sent another quote to Dr. Shamsnia, with effective dates of May 4
to June 28, 2012 (“Revision 12”).11 According to Plaintiffs, Dr. Shamsnia signed the second
page of Revision 12 on May 18, 2012, as instructed by Philips, to reiterate his acceptance of
certain price and financing terms.12 Dr. Shamsnia wrote on page 2 of Revision 12: “Approve the
purchase price of $1,679,661.37 per our previous agreement with one year service contract
included. The purchase financed by Philips financial per previous agreement.”13 Plaintiffs
contend that this note constituted a counteroffer to Revision 12.14 Plaintiffs allege that Philips
never discussed its standard “Terms and Conditions of Sale” with Dr. Shamsnia, and he never
agreed to bind Plaintiffs thereto.15 Dr. Shamsnia later confirmed to Philips that he wanted to
purchase a service contract as a part of the sale of the MRI equipment.16
Plaintiffs allege that, notwithstanding the ongoing communications and negotiations
surrounding the terms and conditions of the sale, Plaintiffs and Philips agreed that Philips would
7
Id.
Id.
9
Id. at 3-4.
10
Id. at 4.
11
Id.
12
Id. at 4.
13
R. Doc. 139-9 at 2.
14
R. Doc. 193 at 5.
15
R. Doc. 47 at 4.
16
R. Doc. 193 at 6-7.
8
3
deliver the MRI equipment to Plaintiffs.17 Dr. Shamsnia, on Plaintiffs’ behalf, agreed to follow
the Philips experts’ instructions and recommendations regarding installation and services.18
Prior to installation of the MRI equipment, the medical facility and the room that were to house
the MRI equipment had to be modeled and constructed according to the Philips experts’ plans
and specifications.19 Plaintiffs began to prepare the second floor of the medical facility to house
the MRI equipment.20 However, Philips informed Dr. Shamsnia that, due to vehicular movement
in the medical facility’s parking lot below, the MRI equipment would have to be located on the
third floor.21 Plaintiffs allege that additional costs were incurred to prepare the third floor of the
medical facility for the MRI equipment, and that Philips asserted that redesigned, special pads
were sufficient to eliminate Plaintiffs’ concerns regarding vibration.22
On December 22, 2014, Philips’ team released the MRI equipment to NAZ and Ad
Neuro, representing that it was safe for patient use.23 At that time, Philips began to request
monthly payments on the MRI package.24 Dr. Shamsnia, on behalf of NAZ, began making
payments to PMC.25 Plaintiffs hired a board-certified MRI technician, who was sent to Philips’
headquarters in Cleveland, Ohio, to receive training on the Ingenia 3.0T Omega MRI before
commencing use of the MRI equipment.26
On January 5, 2015, Plaintiffs began using the MRI equipment on patients and
volunteers.27 On January 12, 2015, the MRI technician noted improper signals during calibration
of the machine as well as gaps and separation of the covers on the MRI equipment.28
17
R. Doc. 47 at 5.
Id.
19
Id.
20
Id.
21
Id.
22
Id. at 5-6.
23
Id. at 6.
24
Id.
25
Id.
26
Id. at 7.
27
Id.
28
Id.
18
4
Immediately, she notified Philips’ engineers.29
That afternoon, a Philips engineer made a site
visit and noticed these changes.30 When the engineer opened the bottom cover of the MRI
equipment, he found a significant and clear shift and sliding of the vibration pads from their
originally-installed location.31 The MRI equipment was inoperable and service was required to
render it safe for operation.32
Plaintiffs then tendered the MRI equipment back to Philips for modifications and
repairs.33 On January 13, 2015, Philips’ senior engineers arrived at the medical facility and
discovered that the MRI equipment had moved inches from where Philips’ engineers had
originally installed it.34 The engineers inquired about the possibility of an earthquake as the
explanation for the movement.35 After inspecting the MRI equipment, the engineers evacuated
the facility based on their concern that the MRI equipment might explode.36
They then
“quenched” the MRI equipment, a process involving de-energizing the MRI equipment and
discharging it of all helium gas; the helium was released through a vent pipe on the roof.37 The
MRI equipment was completely inoperable.38
Two days later, one of Plaintiffs’ employees discovered that water from the prior night’s
heavy rainfall had entered through the roof and flooded the floors, walls, and ceiling of the MRI
room, as well as the floors of the surrounding rooms.39
Plaintiffs allege that, during the
quenching process, Philips’ engineers caused an opening in the roof through which the water
29
Id.
Id.
31
Id.
32
Id.
33
Id.
34
Id.
35
Id.
36
Id. at 7-8.
37
Id. at 8.
38
Id.
39
Id.
30
5
entered the medical facility.40 Plaintiffs allege that they paid $850,000 to repair the property
damage.41
Plaintiffs allege that they had to hire their own experts at their own expense to determine
the cause of the MRI equipment’s malfunction because Philips’ experts could not do so.42
Plaintiffs’ experts allegedly determined that the cause of the malfunction was the movement of
the MRI equipment in normal operation because the support system for the MRI equipment was
supposedly inadequate, which caused the approximately 4,600 kilogram (10,000-plus pound)
magnet to move while the MRI equipment was being used.43
After being notified of the
Plaintiffs experts’ analysis, Philips allegedly admitted that the support system was inadequate.44
Plaintiffs claim that Philips agreed to uninstall and reinstall the MRI equipment.45
Plaintiffs allege that the parties agreed that this remedial work was subject to the oversight,
direction, control, and approval of Philips’ engineers and done according to Philips’
specifications and modifications.46 The work included additional modifications to the door and
the room in which the MRI equipment was housed.47 Plaintiffs allege that, given the continuing
inspections, troubleshooting, repairs, reinstallation, and testing, the MRI equipment was not reactivated until after April 2016, and at that time Plaintiffs discovered that the computer software
and hardware package – components of the “complete package” – that should have been installed
with the MRI equipment had not been installed.48 Because the computer package was allegedly
central to Plaintiffs’ agreement to purchase the MRI equipment from Philips at the particular
40
Id.
Id.
42
Id.
43
Id. at 8-9 & 13.
44
Id. at 9.
45
Id.
46
Id.
47
Id.
48
Id. at 9-10.
41
6
price agreed upon, and because the computer package still has not been delivered, Plaintiffs
claim that Philips has failed to deliver the complete MRI package they purchased.49
To operate the MRI equipment for clinical use, Philips required NAZ and Ad Neuro to
complete advanced training, which did not occur until after May 2016.50 Certification for
clinical use of the MRI equipment by the American College of Radiology was not obtained until
August 2016.51
Plaintiffs further allege that, due to the continuous repair, modification,
reinstallation and redelivery of the MRI equipment, along with the structural alterations to the
building caused by Philips’ actions, they have been unable to compete construction, installation,
and the process of obtaining permits and governmental agency approvals for the operation of the
ambulatory surgery centers in the facility, which has resulted in loss of use and profits.52
On April 4, 2017, NAZ filed this suit against Philips, alleging gross fault (because, as a
manufacturer of highly complex medical diagnostic equipment, Philips should be held to a
heightened standard of care from which Philips grossly deviated) and several breach-of-contract
causes of action: breach of obligation to provide a complete system that would fit NAZ’s
particular purposes, of which Philips was aware, in violation of Louisiana Civil Code article
2524; bad faith breach of contract in violation of Louisiana Civil Code article 1997; bad faith
seller in redhibition in violation of Louisiana Civil Code article 2520; failure to make timely
delivery in violation of Louisiana Civil Code article 2485; and breach of installation and service
agreements.53 NAZ seeks to recover various items of damages.54
On June 12, 2017, Philips moved for a more definitive statement regarding NAZ, LLC’s
members’ identities to determine subject-matter jurisdiction.55 Philips also moved to dismiss any
49
Id. at 10.
Id. at 14.
51
Id.
52
Id. at 10 & 14-15.
53
R. Doc. 1.
54
Id.
55
R. Doc. 11.
50
7
claims arising from an alleged contract of sale, and alternatively sought a more definite statement
of those claims.56 On July 26, 2017, the Court granted the motion in part, ordering NAZ to
amend the complaint to identify the citizenship of its members, but the Court denied the motion
insofar as Philips sought to dismiss the breach-of-contract claims and sought a more definite
statement.57
On September 1, 2017, NAZ filed a supplemental motion for leave to file an amended
complaint, seeking to correct the jurisdictional allegations as to its members, add Dr. Shamsnia
and Ad Neuro as plaintiffs, demand a jury trial, and assert claims for fraud, fraudulent
inducement, and violations of the Louisiana Unfair Trade Practices Act (“LUTPA”) against
Philips.58
NAZ’s fraud, fraudulent inducement, and LUTPA claims were premised on
allegations that Philips did not disclose that the MRI equipment was sold by Philips to PMC and
then sold or leased to NAZ, and that this non-disclosure of “material” information was intended
to induce Dr. Shamsnia into using PMC to finance the purchase of the MRI equipment.59 The
Magistrate Judge granted the motion as to adding Ad Neuro as a plaintiff, and denied the motion
as to adding Dr. Shamsnia as a plaintiff.60 Further, the Magistrate Judge denied the motion as to
adding claims for fraud, fraudulent inducement, and violations of LUTPA against Philips finding
that NAZ failed to show how the alleged omission caused any harm and that NAZ failed to
allege facts with particularity showing that Philips intended to defraud NAZ.61
On November 2, 2017, Plaintiffs filed their first amended complaint.62
Thereafter,
Philips moved for judgment on the pleadings, or alternatively, summary judgment, as to
56
Id.
R. Doc. 25.
58
R. Doc. 36. Previously, on August 3, 2017, NAZ had filed a motion for leave to file an amended
complaint, R. Doc. 27, which the Magistrate Judge denied as moot after NAZ filed the supplemental motion for
leave to file an amended complaint, R. Doc. 37.
59
R. Doc. 45 at 10.
60
Id. at 7-9.
61
Id. at 12-13.
62
R. Doc. 47.
57
8
plaintiffs’ $850,000 claim for property damage arising from the allegedly faulty repair of the
MRI equipment.63 Philips argued that Plaintiffs’ property damage claim arises under the LPLA
and is prescribed.64 Philips also moved to dismiss Plaintiffs’ claims for punitive, exemplary,
non-pecuniary, and economic loss damages.65
The Court denied Philips’ motion seeking
dismissal of the property damage claim; granted Philips’ motion seeking dismissal of Plaintiffs’
claims for punitive, exemplary, and non-pecuniary damages; and denied Philips’ motion to
dismiss Plaintiff’s claims for economic loss damages.66
On May 4, 2018, Plaintiffs filed a motion for leave to file a second amended complaint,
again seeking to assert claims for fraud, fraudulent inducement, fraud by silence, and violations
of LUTPA.67 These fraud-based claims concerned Revision 12.68 Plaintiffs’ purported second
amended complaint alleges that, on May 14, 2012, Philips sent Revision 12 to Dr. Shamsnia,
without explaining that items were removed from Revision 12 that had been included in Revision
10, and requiring him to sign Revision 12 while he was travelling.69 Plaintiffs allege that it was
difficult for Dr. Shamsnia to compare Revision 10 with Revision 12 to ascertain the differences
because the documents are approximately 50 pages each.70
The Magistrate Judge denied
Plaintiffs’ motion, finding that the fraud-based claims, including the LUTPA claim, in the
purported second amended complaint are futile.71 The Magistrate Judge reasoned that Philips
did not attempt to defraud Plaintiffs because Dr. Shamsnia had the full copies of Revision 10 and
Revision 12 that he could have read and compared to discover the differences.72 Plaintiffs
63
R. Doc. 51.
R. Doc. 51-1.
65
R. Doc. 61.
66
R. Doc. 90.
67
R. Doc. 101.
68
R. Doc. 101-3 at 16-21.
69
Id.
70
Id.
71
R. Doc. 156 at 7-8.
72
Id.
64
9
appealed the Magistrate Judge’s denial of their motion for leave to file the second amended
complaint, arguing that the purported fraud-based claims involving Revision 12 are not futile and
that the Magistrate Judge erred by considering material outside of the proposed amended
complaint.73
Between August 21, 2018, and September 4, 2018, Philips filed several motions,
including three motions for summary judgment concerning Plaintiffs’ redhibition claims and the
application of the LPLA, and a motion to strike Plaintiffs’ jury demand on the grounds that
Plaintiffs contractually waived their right to a jury trial.74
II.
LAW & ANALYSIS
a. Philips’ Motions for Summary Judgment (R. Docs. 139, 160 & 163)
Philips filed three motions for summary judgment. Philips moves for summary judgment
on Plaintiffs’ property damage claim, arguing that the claim is governed by the LPLA, and is
prescribed.75 Philips also moves for summary judgment on Plaintiffs’ redhibition claim, arguing
that it is prescribed.76 Finally, Philips argues that all of the claims raised in Plaintiffs’ first
amended complaint, except for the breach-of-contract claim related to the computer software and
hardware and bad faith breach-of-contract claim, are subsumed by the LPLA or redhibition law,
and thus, are prescribed.77 As to the bad faith breach-of-contract claim, Philips argues that there
is no evidence of its acting in bad faith.78
73
R. Doc. 180.
R. Doc. 139, 141, 160 & 163.
75
R. Doc. 139.
76
R. Doc. 160.
77
R. Doc. 163. Philips’ arguments related to the LPLA depend upon whether the parties entered into a
written contract and what the terms of that contract were. The determination of that issue affects how the Court
views Philips’ motions for summary judgment related to the application of the LPLA.
78
Id.
74
10
(i)
Summary Judgment Standard
Summary judgment is proper “if the pleadings, depositions, answers to interrogatories,
and admissions on file, together with the affidavits, if any, show that there is no genuine issue as
to any material fact and that the moving party is entitled to a judgment as a matter of law.”
Celotex Corp. v. Catrett, 477 U.S. 317, 322 (1986) (citing Fed. R. Civ. P. 56(c)). “Rule 56(c)
mandates the entry of summary judgment, after adequate time for discovery and upon motion,
against a party who fails to make a showing sufficient to establish the existence of an element
essential to that party’s case, and on which the party will bear the burden of proof at trial.” Id. A
party moving for summary judgment bears the initial burden of demonstrating the basis for
summary judgment and identifying those portions of the record, discovery, and any affidavits
supporting the conclusion that there is no genuine issue of material fact. Id. at 323. If the
moving party meets that burden, then the nonmoving party must use evidence cognizable under
Rule 56 to demonstrate the existence of a genuine issue of material fact. Id. at 324.
A genuine issue of material fact exists if a reasonable jury could return a verdict for the
nonmoving party.
See Anderson v. Liberty Lobby, Inc., 477 U.S. 242, 248 (1996).
The
substantive law identifies which facts are material. Id. Material facts are not genuinely disputed
when a rational trier of fact could not find for the nonmoving party upon a review of the record
taken as a whole. See Matsushita Elec. Indus. Co., Ltd. v. Zenith Radio Corp., 475 U.S. 574, 587
(1986); Equal Emp’t Opportunity Comm’n v. Simbaki, Ltd., 767 F.3d 475, 481 (5th Cir. 2014).
“[U]nsubstantiated assertions,” “conclusory allegations,” and merely colorable factual bases are
insufficient to defeat a motion for summary judgment. See Anderson, 477 U.S. at 249-50;
Hopper v. Frank, 16 F.3d 92, 97 (5th Cir. 1994). In ruling on a summary judgment motion, a
court may not resolve credibility issues or weigh evidence. See Delta & Pine Land Co. v.
Nationwide Agribusiness Ins. Co., 530 F.3d 395, 398-99 (5th Cir. 2008). Furthermore, a court
11
must assess the evidence, review the facts, and draw any appropriate inferences based on the
evidence in the light most favorable to the party opposing summary judgment. See Tolan v.
Cotton, 572 U.S. 650, __, 134 S. Ct. 1861, 1866 (2014); Daniels v. City of Arlington, 246 F.3d
500, 502 (5th Cir. 2001).
Yet, a court only draws reasonable inferences in favor of the
nonmovant “when there is an actual controversy, that is, when both parties have submitted
evidence of contradictory facts.” Little Liquid Air Corp., 37 F.3d 1069, 1075 (5th Cir. 1994) (en
banc) (citing Lujan v. Nat’l Wildlife Fed’n, 497 U.S. 871, 888 (1990)). Nor must the court
consider uncited evidence in the record. Fed. R. Civ. P. 56(c)(3).
After the movant demonstrates the absence of a genuine dispute, the nonmovant must
articulate specific facts and point to supporting, competent evidence that may be presented in a
form admissible at trial. See Lynch Props., Inc. v. Potomac Ins. Co. of Ill., 140 F.3d 622, 625
(5th Cir. 1998); Fed. R. Civ. P. 56(c)(1)(A) & (c)(2). Such facts must create more than “some
metaphysical doubt as to the material facts.” Matsushita, 475 U.S. at 586. When the nonmovant
will bear the burden of proof at trial on the dispositive issue, the moving party may simply point
to insufficient admissible evidence to establish an essential element of the nonmovant’s claim in
order to satisfy its summary judgment burden. See Celotex, 477 U.S. at 322-25; Fed. R. Civ. P.
56(c)(B). Unless there is a genuine issue for trial that could support a judgment in favor of the
nonmovant, summary judgment must be granted. See Little, 37 F.3d at 1075-76.
(ii)
Prescription of LPLA Claim Related to Property Damage (R. Doc. 139)
Philips moves for summary judgment on Plaintiffs’ claim related to the property damage
sustained by the medical facility after the rain storm in January 2015, which claim Philips
contends is encompassed by the LPLA. Philips characterizes Plaintiffs’ claim as arising from the
alleged movement of the MRI equipment after it was installed, which allowed for water to enter
12
the building resulting in the damages.79 Philips argues that, when viewed in this manner,
Plaintiffs’ allegations frame an LPLA claim in that the use of the MRI equipment resulted in
damage to the building.80
Philips further argues that, because the movement of the MRI
equipment was discovered on January 12, 2015, and Plaintiffs filed their lawsuit more than a
year later, on April 4, 2017, Plaintiffs’ property damage claim is prescribed.81
Plaintiffs respond that their property damage claim is not an LPLA claim arising from the
sale and use of the MRI equipment, but rather a breach-of-contract claim arising from the Philips
engineers’ allegedly faulty repair of the MRI equipment.82 Plaintiffs argue that the Philips
engineers’ repair of the MRI equipment in January 2015 was performed pursuant to a separate
agreement that was neither a warranty nor service agreement entered as part of the initial sale.83
In that vein, Plaintiffs argue that the originating sale, or contract to sell the MRI package,
was formed on December 30, 2011, when Dr. Shamsnia and Philips agreed on the price and the
thing, and the date on which Dr. Shamsnia signed Revision 10.84 Revision 10 had attached to it
Philips’ standard “Terms and Conditions of Sale,” which includes a product warranty.85
However, Plaintiffs argue that Dr. Shamsnia’s signature to Revision 10 signified only Plaintiffs’
agreement to the scope and price of the MRI package and did not bind Plaintiffs to Philips’
standard terms and conditions.86 Plaintiffs further argue that Dr. Shamsnia did not agree to bind
Plaintiffs to Philips’ terms and conditions by signing page 2 of Revision 12, although the
document states that it is subject to Philips’ standard “Terms and Conditions of Sale,” because
Dr. Shamsnia expressly denoted that his assent was subject to Plaintiffs’ prior agreement with
79
R. Doc. 139-1 at 12.
Id.
81
Id. at 12-13.
82
R. Doc. 193 at 8-9 & 11-12.
83
Id. at 11-12.
84
R. Doc. 193 at 14 & R. Doc. 139-5 at 38.
85
Id. at 40.
86
R. Doc. 193 at 2 & 14.
80
13
Philips.87 Thus, Plaintiffs argue that the work Philips did on the MRI equipment in January 2015
was not done pursuant to a warranty as a part of the sale, but was done pursuant to a separate
service agreement the parties entered.88 Therefore, Plaintiffs insist that their property damage
claim arises from Philips’ breach of that alleged separate service agreement as a result of the
Philips engineers’ defective work, and thus their claim does not arise under the LPLA.89
Philips previously raised in its motion for judgment on the pleadings, or alternatively,
motion for summary judgment on Plaintiffs’ property damage claim, the same argument it puts
forth in the pending motion for summary judgment.90 In ruling on that motion, the Court
explained the applicable law as follows:
The LPLA provides “the exclusive theories of liability for manufacturers
for damage caused by their products.” La. Rev. Stat. § 9:2800.52. “Damage” is
defined as “all damage caused by a product, including survival and wrongful
death damages, for which Civil Code Articles 2315, 2315.1, and 2315.2 allow
recovery,” including “damage to the product itself and economic loss arising from
a deficiency in or loss of use of the product only to the extent that Chapter 9 of
Title VII of Book III of the Civil Code, entitled ‘Redhibition,’ does not allow
recovery for such damage or economic loss,” and excluding attorneys’ fees. La.
Rev. Stat. § 9:2800.53(5). In other words, a plaintiff must bring an action under
the LPLA to recover all damages caused by a product, except for damage to the
product itself and economic loss sought under the Chapter 9 Redhibition articles.
See generally John Kennedy, A Primer on the Louisiana Products Liability Act,
49 La. L. Rev. 565 (1989). Grappling with the plain language of the statute and
comments to the Civil Code, courts have struggled to define the scope of this
carve-out. See, e.g., C-Innovation, LLC v. Norddeutsche Seekabelewerke GMBH,
No. 10-4441, 2013 WL 990026, at *4-5 (E.D. La. Mar. 13, 2013); Hollybrook
Cottonseed Processing, LLC v. Carver, Inc. (Hollybrook I), No. 09-0750, 2010
WL 892869, at *6-8 (W.D. La. Mar. 11, 2010). Nevertheless, there is a consensus
that the LPLA does not preclude a redhibitory action against the manufacturer
seeking economic loss damages. See, e.g., Am. Home Assurance Co. v.
Oceaneering Int’l, Inc., 609 F. App’x 171, 176-78 (5th Cir. 2015); Chevron USA,
Inc. v. Aker Maritime, Inc., 604 F.3d 888, 900 (5th Cir. 2010); Hollybrook
Cottonseed Processing, LLC v. Carver, Inc. (Hollybrook II), No. 09-0750, 2010
WL 2195685, at *4-5 (W.D. La. May 28, 2010); Hollybrook I, 2010 WL 892869,
87
R. Doc. 193 at 14 & R. Doc. 139-9 at 2.
Id. at 10-14.
89
Id.
90
See R. Doc. 51.
88
14
at *6-7; Aucoin v. S. Quality Homes, LLC, 2007-1014, p. 7 n.8 (La. 2/26/08); 984
So. 2d 685, 691 n.8.
Where a plaintiff seeks to recover against the manufacturer for damages
other than economic loss in redhibition, the cause of the damage determines the
LPLA’s preclusive effect. Hollybrook II, 2010 WL 2195685, at *4; see also
Hollybrook I, 2010 WL 892869, at *7. Where a plaintiff does not seek damages
caused by the product itself, but, rather, seeks damages based on contractual
obligations beyond the scope of the express or implied warranty for redhibition,
courts have found that the LPLA does not preclude such an action. See, e.g., CInnovation LLC, 2013 WL 990026, at *6-7 (denying a motion to dismiss a fraudbased contractual claim against the manufacturer, reasoning that “[t]he economic
damages C-Innovation is seeking are not by virtue of an action in redhibition and
are not caused by the product itself”); Jack B. Harper Contractor, Inc. v. United
Fiberglass of Am., Inc. (Harper II), No. 11-20, 2013 WL 12238500, at *2, *7
(E.D. La. Jan. 30, 2013) (noting that the jury found the manufacturer liable for
breach of a contractual obligation to provide installation instructions in addition to
liability under two prongs of the LPLA); Jack B. Harper Contractor, Inc. v.
United Fiberglass of Am., Inc. (Harper I), No. 11-20, 2012 WL 2087394, at *2
(E.D. La. June 8, 2012) (denying summary judgment due to “an issue of fact as to
whether Harper’s claims fall solely within the LPLA”); Hollybrook I, 2010 WL
892869, at *7 (granting summary judgment in the defendant’s favor on breach of
contract claims arising from allegedly defective equipment, but denying
defendant’s request for summary judgment as to plaintiff’s claims sounding in
contract, where the contract called for providing equipment to process a certain
daily capacity of cottonseed, as well as “certain engineering, repair, and training
services”), accord Hollybrook II, 2010 WL 2195685, at *3 (clarifying that the
court in Hollybrook I found “that the LPLA precludes Hollybrook’s general
breach of contract claims to the extent they seek damages caused by Carver’s
products”) (emphasis added).
To determine whether the LPLA bars a particular breach of contract cause
of action, the focus is on whether the plaintiff alleges that the damage was caused
by the manufacturer’s product:
While the exclusivity provision of the LPLA leaves no doubt
breach of contract claims against manufacturers for damages
caused by their products are subsumed by the LPLA, in cases
where a specific part of the injury is caused only by the breach of
contract, and not by the product itself, a buyer might be able to
bring both types of claims against a manufacturer. . . . [I]n the
limited circumstances where a buyer sues a manufacturer for
economic damages not covered in redhibition and not caused by
the product itself, it may bring a breach of contract claim for those
damages, on its own or in addition to a claim for other damages
under the LPLA or redhibition.
15
Hollybrook I, 2010 WL 892869, at *7. Thus, when the source of damage is not
the product itself but, for instance, a fraudulent misrepresentation made by the
manufacturer, or a failure to provide services in breach of a contract separate and
apart from the contract of sale, a plaintiff may bring this distinct claim alongside
or independently from an LPLA claim. See C-Innovation, LLC, 2013 WL
990026, at *6-7; Hollybrook I, 2010 WL 892869, at *7. In this context, the LPLA
has not precluded a breach of a contract to provide repairs, nor a claim for
negligent repair against a manufacturer that would be vicariously liable for its
employees’ negligent repair. Hollybrook I, 2010 WL 892869, at *7; see Debose
v. Sam’s East, Inc., No. 09-05, 2010 WL 11468975, at *1-2, *4 n.1 (M.D. La.
Sept. 3, 2010).
On the other hand, when damage is caused by the product, the LPLA
applies to preclude all actions (besides the Chapter 9 carve-out), regardless of the
theory of liability. Hollybrook II, 2010 WL 2195685, at *4-5; see also Am.
Zurich Ins. Co. v. Caterpillar, Inc., 2012-270, pp. 6-7 (La. App. 3 Cir. 10/3/12);
99 So. 3d 739, 743-44 (holding that the LPLA precluded a breach of contract
claim where “no claim relative to the service contract . . . would withstand
distinction from a straight-forward defective product claim”). In this context, the
LPLA has precluded claims for breach of contract and negligent repair. Stroderd
v. Yamaha Motor Corp., U.S.A., No. 04-3040, 2005 WL 2037419, at *2 (E.D. La.
Aug. 4, 2005). Moreover, the buyer may not recover damage to other property
besides the product itself that was caused by the defective product. Chevron USA,
Inc., 604 F.3d at 900-01.91
Applying this law to the instant suit, the Court denied Philips’ motion for judgment on
the pleadings, or alternatively, for summary judgment, observing that Plaintiffs alleged that their
property damage was caused by the Philips engineers’ breach of their obligation to repair the
MRI equipment under a service agreement that was “separate and apart from the contract of sale
and redhibitory warranty.”92 Thus, the Court held that Plaintiffs’ property damage claim was not
subsumed by the LPLA because Plaintiffs alleged that “it was not the MRI alone that caused the
Plaintiffs to sustain water damage.”93 The Court further noted that it was “premature to consider
summary judgment where the parties dispute the existence of a contract.”94
91
R. Doc. 90 at 19-23 (footnotes omitted).
Id. at 26.
93
Id. at 28.
94
Id.
92
16
At this time, there are outstanding issues of material fact that preclude summary
judgment on Philips’ assertion that Plaintiffs’ property damage claim arises under the LPLA and
is prescribed. First, there is a dispute as to the cause of the property damage. Philips argues that
the property damage was caused by the movement of the MRI equipment during use, which
allowed for water to enter the building.95 Plaintiffs, on the other hand, contend that the property
damage was caused by the Philips engineers’ improperly performing the quenching process,
which caused a hole in the roof that allowed water to enter the building.96 Second, there is a
dispute as to whether the quenching process was performed under a warranty attending the sale
or under a separate service agreement confected after the initial sale. If Philips is correct that the
damage was caused by the movement of the MRI equipment during use and that the repair work
was done pursuant to a warranty flowing from the sale, then the LPLA would apply. However, if
Plaintiffs are correct that the damage was caused by the engineers’ actions during the quenching
process and the work was performed pursuant to a separate service agreement, then the LPLA
does not apply. Due to these disputed issue of material fact, Philips’ motion for summary
judgment regarding the prescription of Plaintiffs’ “LPLA claim” related to the property damage
is DENIED.
(iii)
Prescription of Redhibition Claim (R. Doc. 160)
Philips argues that Plaintiffs’ redhibition claim has prescribed because Philips tendered
the MRI equipment back to Plaintiffs on February 26, 2016, after the repair, and that Plaintiffs
filed suit more than a year later, on April 4, 2017.97 Plaintiffs argue that their redhibition claim
has not prescribed because they did not discover that the MRI equipment was not properly
repaired until sometime after April 4, 2016.98 Plaintiffs also assert that the MRI equipment was
95
R. Doc. 139-1 at 12.
R. Doc. 47 at 8.
97
R. Doc. 160-1 at 6-7.
98
R. Doc. 196 at 5-6.
96
17
not employed in clinical use until after April 4, 2016, due to Philips’ failure to deliver the
extended workstation.99
Under Louisiana law, a “seller warrants [a] buyer against redhibitory defects, or vices, in
the thing sold.” La. Civ. Code art. 2520. A seller that manufactures the thing it sells, such as
Philips, is deemed to know that the thing it sells has a redhibitory defect. La. Civ. Code art.
2545. Prescription for a seller that is deemed to know of a redhibitory defect runs “one year
from the day the defect was discovered by the buyer.” La. Civ. Code art. 2534(B). However,
“prescription is interrupted when the seller accepts the thing for repairs and commences anew
from the day [it] tenders [the thing] back to the buyer or notifies the buyer of [its] refusal or
inability to make the required repairs.” La. Civ. Code art. 2534(C). “[I]f the repair attempt is
believed to have corrected the redhibitory defect, the prescription in favor of the seller does not
begin to run again until the defects reappear and are discovered to be such by the buyer.” Brown
v. Dauzat, 157 So. 2d 570, 574 (La. App. 1963) (citing Hermeling v. Whitmore, 140 So. 2d 257
(La. App. 1961)); see also Panagiotis v. Gauthier-Matherne Homes, Ltd., 571 So. 2d 881, 883
(La. App. 1990) (same); McKneely v. Don Coleman Const. Co., Inc., 441 So. 2d 497, 499 (La.
App. 1983) (same). “The burden of proof is normally on the party pleading prescription;
however, if on the face of the petition it appears that prescription has run ... the burden shifts to
the plaintiff to prove a suspension or interruption of the prescriptive period.” Younger v.
Marshall Indus., Inc., 618 So. 2d 866, 869 (La. 1993).
Philips tendered the MRI equipment back to Plaintiffs on February 26, 2016, and
Plaintiffs filed suit more than a year later. Thus, it appears on the face of the complaint that
prescription has run. As a result, Plaintiffs have the burden of proving that it has not. Plaintiffs
have carried their burden by establishing that there are disputed issues of material fact regarding
99
Id.
18
when the alleged redhibitory defect reappeared and when Plaintiffs discovered that Philips did
not fix the problem. First, Plaintiffs’ purported expert in material sciences, Dr. Thomas L. Read,
stated in his affidavit that the MRI equipment has never been properly repaired in terms of
movement and is still not fit for its intended use.100 In addition, on November 13, 2017, and
January 12, 2018 (dates after this suit was filed), Plaintiffs requested that Philips provide service
on the MRI equipment because Plaintiffs think it is still moving.101 Philips contends that the
MRI equipment is fit for its intended use and Plaintiffs have used it to conduct MRI exams.102
The question of when Plaintiffs discovered that Philips’ repair did not fix the alleged redhibitory
defect, so as to commence the running of prescription anew, is a factual issue that cannot be
resolved on a motion for summary judgment. Therefore, Philips’ motion for summary judgment
regarding Plaintiffs’ redhibition claim is DENIED.
(iv)
Preclusive Effects of LPLA and Redhibition (R. Doc. 163)
Philips argues that all of the claims raised in Plaintiffs’ first amended complaint, except
for the breach-of contract claim related to the computer software and hardware and bad faith
breach-of-contract claim, are subsumed by the LPLA or redhibition, and thus, prescribed.103 As
explained above, there remain disputed issues of material fact pertinent to determining whether
Plaintiffs’ claims are encompassed by the LPLA – specifically, what caused the damage to the
MRI equipment and whether the parties entered into a service contract that was separate and
apart from the initial sale. Further, there remain disputed issues of material fact that preclude
summary judgment on Plaintiffs’ redhibition claim – specifically, when Plaintiffs discovered that
Philips’ repair did not fix the alleged defect.
100
R. Doc. 196-3 at 1-2.
See R. Doc. 196-4.
102
R. Doc. 206 at 3.
103
R. Doc. 163.
101
19
As to the bad faith breach-of-contract claim, Philips argues that there is no evidence of its
acting in bad faith.104 However, Plaintiffs point to evidence of alleged misrepresentations made
by Philips’ employees as to the price, the exact package Plaintiffs purchased, quote revisions,
and the movement of the MRI equipment, that Plaintiffs contend demonstrates Philips’ bad faith
breach of the contract.105 As discussed above, there are numerous disputed issues of material
fact regarding the terms and scope of the parties’ contract or contracts, and these issues must be
resolved before it can be determined whether Philips breached any contract(s) in bad faith.
For these reasons, Philips’ motion for summary judgment on the preclusive effects of the
LPLA and redhibition is DENIED.
b. Philips’ Motion to Strike Plaintiffs’ Jury Demand (R. Doc. 141)
Philips moves to strike Plaintiffs’ jury demand, arguing that Plaintiffs contractually
waived the right to a jury trial. Philips contends that, by accepting the MRI equipment, Plaintiffs
assented to Philips’ standard “Terms and Conditions of Sale,” which include the following
provision:
EACH PARTY, KNOWINGLY AND AFTER CONSULTATION WITH
COUNSEL, FOR ITSELF, ITS SUCCESSORS AND ASSIGNS, WAIVES ALL
RIGHT TO TRIAL BY JURY OF ANY CLAIM ARISING WITH RESPECT TO
THIS AGREEMENT OR ANY MATTER RELATED IN ANY WAY
THERETO.106
The Seventh Amendment to the Constitution of the United States preserves the right to a
jury trial in civil suits. U.S. Const. amend. VII; see also Fed. R. Civ. P. 38(a) (“The right of trial
by jury as declared by the Seventh Amendment to the Constitution – or as provided by a federal
statute – is preserved to the parties involved.”). However, the right to a jury trial can be waived
by prior written agreement of the parties. K.M.C. Co., Inc. v. Irving Trust Co., 757 F.2d 752, 755
104
Id.
R. Doc. 195 at 8-9.
106
R. Doc. 141-1 at 2-3.
105
20
(6th Cir. 1985). A written agreement waiving the right to a jury trial is enforceable if the waiver
was made knowingly, voluntarily, and intelligently. Jennings v. McCormick, 154 F.3d 542, 545
(5th Cir. 1998). Courts consider the following factors to determine whether a waiver of a jury
trial has been made knowingly and voluntarily: “(1) whether the terms of the contract were
negotiable, (2) the conspicuousness of the jury waiver provision, (3) the relative bargaining
power of the parties, (4) whether [the waiving party] was represented by counsel, and (5) [the
waiving party's] business acumen.” Evans v. Union Bank of Switzerland, 2003 WL 21277125, at
*2 (E.D. La. May 30, 2003) (quoting Pellerin Constr., Inc. v. Witco Corp., 2001 WL 258056, at
*1 (E.D. La. Mar. 14, 2001)). As noted by the Fifth Circuit, “[t]he right of jury trial is
fundamental, [and] courts [must] indulge every reasonable presumption against waiver.”
Jennings, 154 F.3d at 545.
As discussed above, Philips’ standard “Terms and Conditions of Sale” were attached to
both Revision 10 and Revision 12, which Dr. Shamsnia received on Plaintiffs’ behalf.107
However, Plaintiffs contend that Dr. Shamsnia never agreed to the terms and conditions, that
Revision 10 merely reflects the price and thing agreed upon, that Revision 12 was merely a
counteroffer, and that neither was a contract outlining the terms and conditions of sale.108
Under Louisiana law, the formation of a valid contract requires: (1) capacity to contract;
(2) mutual consent; (3) a certain object; and (4) a lawful cause. La. Civ. Code arts. 1918, 1927,
1966, 1971 & 2029. A sales contract also requires the parties’ agreement on the thing and the
price. Id. art. 2439. A contract is formed by a meeting of the minds as expressed through offer
and acceptance. Id. art. 1927. To form a contract, an acceptance must conform to the offer;
otherwise it is a counteroffer. Id. art. 1943. A modification in the purported acceptance of an
107
R. Doc. 141-1 at 2-3.
R. Doc. 187 at 15. Interestingly, although Plaintiffs contend that they never agreed to Philips’ standard
“Terms and Conditions of Sale” that were part of the Revision 10 Dr. Shamsnia signed, Plaintiffs allege that
Revision 10 is the version of the contract to which they agreed in terms of the price and scope of what they thought
they were purchasing. See R. Doc. 47.
108
21
offer constitutes a new offer which must be accepted by the other party in order to create a
binding contract. Rodrigue v. Gebhardt, 416 So. 2d 160 (La. App. 1982).
In this case, there are disputed issues of material fact regarding whether the parties
entered into a written contract that incorporates Philips’ standard “Terms and Conditions of
Sale,” which include the waiver of a jury trial. Plaintiffs contend that they did not agree to any
of the written terms and conditions of sale, and Philips cannot point to an undisputed writing that
establishes otherwise.
Thus, Philips has not demonstrated that Plaintiffs knowingly and
voluntarily waived their right to a jury trial. Whether Plaintiffs waived their right to a jury trial
is entirely dependent on whether the parties had a written contract and what the terms of any
such contract are. These are questions the fact-finder, i.e. the jury, must answer. However, if the
jury finds that either Revision 10 or Revision 12, which both include the jury waiver clause, is
the parties’ contract, then the Court will determine, in accordance with the five-factor test,
whether Plaintiffs’ jury waiver was made knowingly and voluntarily. If the Court finds that
Plaintiffs made the jury waiver knowingly and voluntarily, the remainder of the issues must be
tried in a bench trial.
Therefore, for now, Philips’ motion to strike Plaintiffs’ jury demand is DENIED. The
trial of this matter will proceed in two phases. First, the jury will be asked to determine whether
the parties entered into a written contract concerning the purchase of the MRI equipment and
package, and if so, what the terms of that contract are. If the jury finds that Philips’ standard
“Terms and Conditions of Sale” were incorporated into a written contract that binds the parties,
the Court will determine if Plaintiffs knowingly and voluntarily waived the jury; and if they did,
the remainder of the issues will be tried in a bench trial. On the other hand, if the jury finds that
Philips’ standard “Terms and Conditions of Sale” were not incorporated into a binding written
22
contract or the Court finds that Plaintiffs’ jury waiver was not made knowingly and voluntarily,
then the remainder of the issues will be tried by the jury.
c. Plaintiffs’ Appeal of the Magistrate Judge’s Decision (R. Doc. 180)
Plaintiffs seek review of the Magistrate Judge’s denial of Plaintiffs’ motion for leave to
file a second amended complaint to assert claims for fraud, fraudulent inducement, fraud by
silence, and violations of LUTPA related to Dr. Shamsnia’s signing page 2 of Revision 12.
Magistrate judges are empowered to “hear and determine” certain non-dispositive pretrial
motions, including a motion for leave to amend the complaint. 28 U.S.C. § 636(b)(1)(A); see
also PYCA Indus., Inc. v. Harrison Co. Waste Water Mgmt. Dist., 81 F.3d 1412, 1421 n.11 (5th
Cir. 1996). If a party is dissatisfied with a magistrate judge's ruling, it may appeal to the district
court. Fed. R. Civ. P. 72(a). When a timely objection is raised, the district court will “modify or
set aside any part of the order that is clearly erroneous or is contrary to law.” Id.; see also 28
U.S.C. § 636(b)(1)(A). The court reviews the magistrate judge's “factual findings under a clearly
erroneous standard, while legal conclusions are reviewed de novo.” Moore v. Ford Motor Co.,
755 F.3d 802, 806 (5th Cir. 2014) (internal citation omitted). A factual “finding is ‘clearly
erroneous’ when although there is evidence to support it, the reviewing court on the entire
evidence is left with the definite and firm conviction that a mistake has been committed.” United
States v. U.S. Gypsum Co., 333 U.S. 364, 395 (1948).
Courts are to “freely give leave [to amend] when justice so requires.” Fed. R. Civ. P.
15(a). The Supreme Court has held that “[i]f the underlying facts or circumstances relied upon
by a plaintiff may be a proper subject of relief, he ought to be afforded an opportunity to test his
claim on the merits.” Foman v. Davis, 371 U.S. 178, 182 (1962). However, leave to amend is
not automatic. Halbert v. City of Sherman, 33 F.3d 526, 529 (5th Cir. 1994). Courts consider
multiple factors, including “undue delay, bad faith or dilatory motive on the part of the movant,
23
repeated failure to cure deficiencies by amendments previously allowed, undue prejudice to the
opposing party by virtue of allowance of the amendment, [and] futility of amendment.” Foman,
371 U.S. at 182. An amendment is futile if it would be dismissed under a Rule 12(b)(6) motion.
Marucci Sports, LLC v. Nat'l Collegiate Athletic Ass'n, 751 F.3d 368, 378 (5th Cir. 2014).
The Magistrate Judge correctly found that amendment would be futile because Plaintiffs’
proposed amended complaint does not add new theories of recovery under which Plaintiffs could
recover. The fraud-based allegations of the proposed second amended complaint revolve around
Philips’ presentation of Revision 12 to Dr. Shamsnia and his signing that document.109 Plaintiffs
allege that Philips never explained to Dr. Shamsnia how Revision 12 differed from Revision
10.110 However, Plaintiffs do not allege that Dr. Shamsnia was not given a complete copy of
Revision 12.111 Indeed, Plaintiffs’ counsel admitted to the Magistrate Judge at oral argument on
the motion for leave to amend that Dr. Shamsnia had copies of both Revision 10 and Revision 12
at the time he signed page 2 of Revision 12.112 The Magistrate Judge correctly concluded that
Dr. Shamsnia, a highly educated person, could have read Revision 12 and compared it to
Revision 10 to ascertain the differences; thus, Philips did not attempt to conceal information
from Dr. Shamsnia as would constitute fraud or violations of LUTPA.113
Therefore, the
Magistrate Judge’s order denying Plaintiffs’ motion for leave to file a second amended complaint
is neither clearly erroneous nor contrary to law and, consequently, is AFFIRMED.
III.
CONCLUSION
Accordingly, IT IS ORDERED that Philips’ motion for partial summary judgment
regarding prescription of Plaintiffs’ LPLA claim, R. Doc. 139, is DENIED;
109
See R. Doc. 180-2.
Id. at 16-21.
111
See R. Doc. 180-2.
112
R. Doc. 200 at 33. The Court is not now making any determinations regarding the import of Dr.
Shamsnia’s signature on page 2 of Revision 12, which constitutes yet another factual dispute between the parties.
113
R. Doc. 156 at 7-8.
110
24
IT IS FURTHER ORDERED that Philips’ motion for partial summary judgment
regarding prescription of Plaintiffs’ redhibition claims, R. Doc. 160, is DENIED;
IT IS FURTHER ORDERED that Philips’ motion for partial summary judgment
regarding the preclusive effects of the application of the LPLA and Louisiana redhibition law, R.
Doc. 163, is DENIED;
IT IS FURTHER ORDERED that Philips’ motion to strike Plaintiffs’ jury demand, R.
Doc. 141, is DENIED; and
IT IS FURTHER ORDERED that the Magistrate Judge’s order denying Plaintiffs’
motion for leave to file a second amended complaint, R. Doc. 156, is AFFIRMED.
New Orleans, Louisiana, this 7th day of November 2018.
________________________________
BARRY W. ASHE
UNITED STATES DISTRICT JUDGE
25
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?